CN Patent

CN101583620A — 加奈索酮组合物及其制备和使用方法

Assigned to Immedica Pharma US Inc · Expires 2009-11-18 · 16y expired

What this patent protects

在某些实施方案中，本发明涉及包括含有加奈索酮的稳定的粒子的组合物，其中所述粒子的体积加权中值直径(D50)为约50nm至约500nm。

USPTO Abstract

在某些实施方案中，本发明涉及包括含有加奈索酮的稳定的粒子的组合物，其中所述粒子的体积加权中值直径(D50)为约50nm至约500nm。

Drugs covered by this patent

Ztalmy (GANAXOLONE) · Marinus

Patent Metadata

Patent number: CN101583620A
Jurisdiction: CN
Classification: —
Expires: 2009-11-18
Drug substance claim: No
Drug product claim: No
Assignee: Immedica Pharma US Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.